Microsulis Medical lands FDA clearance for its Accu2i pMTA percutaneous microwave ablation device.

Denmead, England-based Microsulis Medical Ltd., a medical device maker focusing on minimally invasive soft tissue ablation, won FDA clearance for its Accu2i pMTA percutaneous microwave ablation device.
The next-generation device features an ergonomic redesign with ridged contact points, a more tactile feel and features which allows the user to see the coolant flowing through the applicator, according to the press release.
The FDA hits Endologix's catheter introducer device recall with Class I status, its most serious...
A blogger's speculation that pSivida might be in line for a buyout bid sends the ophthalmology...
Experts fear the online health insurance marketplace will be burdened with tech problems and...
Women's health company Mirabilis Medica lands up to $13 million in Series A round to back its...